Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v9-FR
Language French French
Date Updated 2023-03-21 2023-03-17
Drug Identification Number 02048485 02048485
Brand name NOLVADEX-D TAB 20MG NOLVADEX-D TAB 20MG
Common or Proper name tamoxifen citrate tamoxifen citrate
Company Name ASTRAZENECA CANADA INC ASTRAZENECA CANADA INC
Ingredients TAMOXIFEN TAMOXIFEN
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 tablets 30 tablets
ATC code L02BA L02BA
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2023-03-21 2023-03-21
Actual discontinuation date 2023-03-21
Remaining supply date 2023-03-21 2023-03-21
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments